Analyst Ratings For Alpine Immune Sciences (NASDAQ:ALPN)
Today, Ladenburg Thalmann Financial Services initiated coverage on Alpine Immune Sciences (NASDAQ:ALPN) with a Buy with a price target of $17.00.
There are 1 buy rating on the stock.
The current consensus rating on Alpine Immune Sciences (NASDAQ:ALPN) is Buy (Score: 3.00) with a consensus target price of $17.00 per share, a potential Infinity upside.
Some recent analyst ratings include
- 7/27/2017-Ladenburg Thalmann Financial Services initiated coverage with a Buy rating.
Recent Trading Activity for Alpine Immune Sciences (NASDAQ:ALPN)
Shares of Alpine Immune Sciences closed the previous trading session at 8.72 down -0.06 -0.68% with 28,876 shares trading hands.